omniture
from common-pcom:html:key:en_segment_includes_overall_segment_header_shtml
PR Newswire: news distribution, targeting and monitoring
Home Page > News Releases > Global
en_US zh_TW

Kingworld Medicines to Launch Puji Anti-flu Granules

2012-02-16 09:45

To Further Expand in Hong Kong Market

HONG KONG, Feb. 16, 2012 /PRNewswire-Asia/ -- Kingworld Medicines Group Limited ("Kingworld Medicines" or the "Company" and, together with its subsidiaries, the "Group", Stock code: 01110), a distributor of renowned branded imported pharmaceutical and healthcare products in the PRC, announced that Kingworld Medicine Healthcare Limited ("HK Kingworld"), a subsidiary of the Group will begin to sell its new product Puji Anti-flu Granules, which is developed by a national experienced team, this year after the launch of Nin Jiom Lingzhi Mel in 2011. The move will help the Group further expand in the Hong Kong market.

Strong demand for influenza medicines  Puji Anti-flu Granules gives effective results

According to the Centre for Health Protection under the Department of Health, influenza ("flu") is an acute illness of the respiratory tract caused by flu viruses. There are three types of flu viruses which are commonly known, namely Type A, B and C. The clinical symptoms of flu include fever, cough, sore throat, nasal discharge, muscle pain, fatigue and headache; or vomiting and diarrhoea in some cases. Flu viruses can be spread through droplets when an infected person coughs, sneezes or talks, which may resulted in a pandemic. In August 2010, the World Health Organization announced that the world had moved into the post-pandemic period and the Type A (H1N1) virus was expected to continue to circulate in the region's community as a seasonal flu strain for a few years to come.

Influenza vaccination is one of the effective ways to prevent flu. Since new strains emerge from time to time, and the effectiveness of flu vaccine may drop depending on how well it tackles other subtypes of flu viruses. As a result, it is necessary to develop flu medicines and the demand is strong.

Puji Anti-flu Granules is developed and produced by Yuen Tai Pharmaceuticals Limited ("Yuen Tai Pharmaceuticals"), whose experienced team conducting research and development based on classic formulae. The significant effects of Puji Anti-flu Granules have been proved by stringent clinical trials. The product treats fever, sore throat or dry throat caused by flu, and flu. Puji Anti-flu Granules is in the process of getting approval. It will be manufactured by Yuen Tai Pharmaceuticals when the approval is obtained; Puji Anti-flu Granules will be distributed by HK Kingworld and will be available for sale in Hong Kong.

About Kingworld Medicines Group Limited

Kingworld Medicines Group Limited is principally engaged in the distribution of branded imported pharmaceutical and healthcare products in the PRC. The Group ranked among the top 100 importers of its kind in China in 2010 based on imported value. The Group managed a portfolio of 60 products under 10 different functional categories which are manufactured in Japan, Canada, Hong Kong, Taiwan, Thailand and the PRC and sourced from 13 different suppliers. Many of which are established brand names including Nin Jiom Pei Pa Koa, Taiko Seirogan, Kawai Liver Oil Drop series, Flying Eagle Wood Lok Medicated Oil, Imada Red Flower Oil, Kyushin Pill and Mentholatum series.

For enquiries, please contact:

Porda Havas International Finance Communications Group 
Ms. Peony Sze +852-3150-6766 peony.sze@pordahavas.com
Mr. Ivan Kau +852-3150-6778 ivan.kau@pordahavas.com
Ms. Mona Chow +852-3150-6765 mona.chow@pordahavas.com
Mr. Justin Doone +852-3150-6703 justin.doone@pordahavas.com
Fax: +852-3150-6728
Source: Kingworld Medicines Group Limited
from common-pcom:html:key:en_segment_includes_releases_right_column_video_module_shtml

Featured Video

Related Keywords:

Banking/Financial Service

from common-pcom:html:key:en_segment_includes_overall_segment_footer_shtml
Advanced Search
Search
  
  1. Products & Services
  2. News Releases
  3. Knowledge Center
  4. Journalists & Media
  5. Multimedia Theater
  6. Contact Us